View in EDS HTML Full Text PDF Full Text

Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Saved in:
Bibliographic Details
Title: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.
Authors: Bertrand L; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Nelde A; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Ramirez BC; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., Hatin I; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., Arbes H; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., François P; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., Demais S; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., Labaronne E; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; ADLIN Science, Evry-Courcouronnes, France., Decimo D; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France., Guiguettaz L; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France., Grégoire S; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Bet A; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Beauclair G; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., Gross A; IRIM, UMR 9004, CNRS, Université de Montpellier, Montpellier, France., Ziegler MC; Leibniz Institute of Virology, Hamburg, Germany., Pereira M; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Jeger-Madiot R; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Verdier Y; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France., Vinh J; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France., Cardinaud S; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Vaccine Research Institute (VRI), INSERM-U955 (IMRB) Équipe 16, Université Paris-Est Créteil (UPEC), Créteil, France., Graff-Dubois S; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Esclatine A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France., Gouttefangeas C; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany., Altfeld M; Leibniz Institute of Virology, Hamburg, Germany., Hocqueloux L; Centre Hospitalier Universitaire d'Orléans, Orléans, France., Samri A; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Autran B; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France., Lambotte O; Université Paris Saclay, Inserm, CEA, AP-HP, UMR1184 IDMIT, Department of Internal Medicine & Clinical Immunology, Bicêtre Hospital, Le Kremlin-Bicêtre, Bicêtre, France., Rammensee HG; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany., Ricci EP; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France., Walz J; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076, Tübingen, Germany., Namy O; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. olivier.namy@i2bc.paris-saclay.fr., Moris A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. arnaud.moris@i2bc.paris-saclay.fr.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France. arnaud.moris@i2bc.paris-saclay.fr.
Source: Nature communications [Nat Commun] 2025 Feb 18; Vol. 16 (1), pp. 1707. Date of Electronic Publication: 2025 Feb 18.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-025-56773-2